Opus Genetics
Price & Volume
Stats
See more52W Range | $0.65-$1.86 |
Market Cap | $108.4M |
Shares Short | 90,128 |
Financials
See moreRevenue (12 Mos) | $15.4M |
Revenue Growth (YoY) | 159.2% |
Gross Profit (12 Mos) | -$14.5M |
Diluted EPS | -$1.85 |
News
See moreYahoo Finance • 2 days ago
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
Yahoo Finance • 20 days ago
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Form 8K Opus Genetics Inc For: 25 August
Yahoo Finance • last month
Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1
About
CEO | Mr. George Magrath M.B.A., M.D., M.S. |
CFO | Mr. Robert E. Gagnon |
Address | 8 Davis Drive, Durham, NC, United States, 27709 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 18 |
